New data from two phase 3 studies found that in patients with relapsing forms of multiple sclerosis (MS), the new anti-CD20 monoclonal antibody drug, ublituximab, is associated with significant ...

Opinions expressed by Entrepreneur contributors are their own. In this digital age, competition seems to be more rampant than ever. The attention of customers is scattered due to the many choices they ...

Ultimate Growth Investing (UGI) Free Access offers some insights into what our subscribers receive in the Basic and Full Access. Limited access to market analysis, occasional trade alerts, and a price ...

We independently evaluate all of our recommendations. If you click on links we provide, we may receive compensation. Michael is a former senior editor of investing and trading products for ...